PPIs Should Be Used 'Judiciously' in Patients With Cirrhosis

Experts call for 'nuanced' prescribing of proton pump inhibitors to patients with cirrhosis in a study that found lower mortality only in those with gastrointestinal bleeding.

Related Keywords

Miami ,Florida ,United States ,Philadelphia ,Pennsylvania ,Rush University ,Illinois ,University Of Pennsylvania ,University Of Miami ,Chicago ,Paul Martin ,Nadim Mahmud ,Large Study Suggests Limited Protective ,University Of Miami Health Systems ,Rush Medical College ,Division Of Hepatology ,Perelman School Of Medicine ,Perelman School ,Medscape Medical News ,Big Picture ,People With ,Veterans Outcomes ,Costs Associated ,Liver Diseases ,Medscape Medical ,Miami Health Systems ,Biliary Disease ,Allbladder Disease ,Cirrhosis ,Gastrointestinal Hemorrhage ,Gastrointestinal Bleeding ,Leeding Gastrointestinal ,Fatty Liver ,Teatorrhoeic Hepatosis ,Teatosis Hepatis ,Nonalcoholic Fatty Liver Disease ,Vafld ,Proton Pump Inhibitor ,Cid Suppressive Therapy ,Pi Proton Pump Inhibitor ,Herapy Acid Suppressive ,Transplantation Liver ,Epatic Transplantat ,